Back to Directory
research logo

Cytovale | Company Profile

12/4/2025

Contact Information

πŸ‘€
Cytovale
🏒
Cytovale
πŸ“
2 Tower Pl, 18th Floor, South San Francisco, California 94080, US

Industry & Market

Primary Industry
research
Location
South San Francisco, California, United States

Company Metrics

πŸ‘₯Total Employees
91
βš™οΈEngineering
48
πŸ’ΌSales Team
2
πŸ“ˆMarketing
4
πŸ“…Founded
2013
πŸ’°Revenue
33M

Funding Information

Total Funding
$242.4M
Latest Stage
Series d
Annual Revenue
$33,000,000

Headcount Distribution

Total Employees
91
Departments
19

By Department

Department Breakdown

Engineering
Business Development
Operations
Consulting
Entrepreneurship
Marketing
Others

Technology Stack

Analytics & Tracking

Google Tag Manager

Social & Marketing

Google Dynamic Remarketing

Video & Media

Vimeo

Email & Communication

GmailOutlook
Total: 15 technologies

Keywords & Focus Areas

medical devicebiotechnology researchimmune activationimmune cell imagingservicessepsis managementimmune response profilinghigh-resolution cell imaginghigh throughput imagingb2bimmune cell behavior analysisimmune cell mechanical propertiesimmune cell stiffnessmachine learningmedical devicessepsispatient triage toolslaboratory automationbiomechanical cell analysisrapid diagnostic technology+10 more
30 total keywords

Cytovale

Overview

Cytovale is a medical diagnostics company based in South San Francisco, focused on developing rapid diagnostic technologies for fast-moving and immune-mediated diseases, particularly early sepsis detection. Founded in 2013, the company emerged from academic research that began in 2007. Cytovale combines the expertise of biologists, data scientists, and engineers to create innovative diagnostic tools that analyze the innate immune response.

The flagship product, IntelliSep, is an FDA-cleared rapid sepsis diagnostic test that utilizes advanced microfluidics and machine learning to analyze white blood cells from a standard blood draw. This test measures immune system dysregulation and can stratify a patient’s risk of sepsis in about eight to ten minutes, enabling timely and accurate detection in emergency departments. The technology platform, Cytovale System, further enhances this capability by isolating, imaging, and analyzing cells to assess immune activation. The company aims to expand its technology to other immune-related diagnostic applications in the future.

Basic Information

Industry Research
Founded 2013
Revenue 33M
Headquarters 2 Tower Pl, 18th Floor, South San Francisco, California 94080, United States

Contact Details

Key Focus Areas & Initiatives

  • Medical device development
  • Biotechnology research
  • Immune activation & immune cell imaging
  • Sepsis management & early detection
  • Immune response profiling
  • High throughput and resolution cell imaging
  • Machine learning-based diagnostics
  • B2B healthcare solutions
  • Laboratory automation and workflow integration
  • Biomechanical cell analysis
  • Rapid diagnostic technology
  • Microfluidic deformability cytometry
  • FDA-cleared sepsis test
  • Patient triage and risk stratification tools
  • Clinical decision support
  • Healthcare innovation and cost efficiency

Technologies Used

  • AI
  • CloudFlare Hosting
  • DoubleClick
  • DoubleClick Conversion
  • Gmail
  • Google Apps
  • Google Dynamic Remarketing
  • Google Tag Manager
  • Gravity Forms
  • Microsoft Office 365
  • Mobile Friendly
  • Outlook
  • Remote
  • Vimeo
  • WordPress.org

Affiliated Organizations & Regional Branches

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free
SayData

Β© 2026 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube